ADHD Medications Show Different Suicide Risk Patterns in Children
Large FDA database analysis reveals methylphenidate may reduce suicide risk while atomoxetine increases it in pediatric ADHD patients.
446 articles in this topic
Large FDA database analysis reveals methylphenidate may reduce suicide risk while atomoxetine increases it in pediatric ADHD patients.
New analysis reveals how political contempt patterns damage international health cooperation and medical advancement worldwide.
New perspective highlights nurses' unique role in bridging research and public health messaging during health crises.
12-week mindfulness exercise program significantly improved motor tics, anxiety, and daily functioning in 121 children with Tourette syndrome.
Systematic review of 15 studies finds Kundalini yoga improves memory, reduces anxiety and PTSD, and enhances sleep quality with no serious side effects.
Large international study reveals how current antidepressant use affects brain structure in people with major depression.
NMDA receptor antagonist memantine restored social and recognition memory deficits caused by chronic methamphetamine exposure.
Comprehensive review reveals how MECP2 mutations disrupt brain development and function in Rett syndrome, highlighting emerging therapeutic targets.
MRI study reveals disrupted neurotransmitter balance in periaqueductal gray of chronic low back pain patients, potentially explaining treatment resistance.
Novel body-based therapy increased oxytocin levels by 46% and reduced psychological distress in medical professionals.
New research protocol explores how breathing techniques could support individual, collective, and planetary wellbeing beyond traditional stress reduction.
Review explores advanced drug delivery systems and analytical methods to improve donepezil effectiveness for Alzheimer's disease.